S230: HUMAN ΒETA-DEFENSIN 2 TREATMENT MODULATES THE INTESTINAL MICROBIOME AND THE ALLOGENEIC T CELL RESPONSE TO LIMIT ACUTE GRAFT-VERSUS-HOST DISEASE

• T. Rückert,
• G. Andrieux,
• M. Boerries,
• N. M. Woessner,
• S. Minguet,
• S. Doetsch,
• K. Aumann,
• M Schiff,
• L. M. Braun,
• E. Haring,
• B. A. Siranosian,
• A. S. Bhatt,
• P. Nordkild,
• J. Wehkamp,
• B. A. H. Jensen,
• J. Duyster,
• R. Zeiser,
• N. Köhler

Affiliations

T. Rückert

1 Department of Medicine I

G. Andrieux

2 Institute of Medical Bioinformatics and Systems Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg

M. Boerries

2 Institute of Medical Bioinformatics and Systems Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg

N. M. Woessner

4 Faculty of Biology

S. Minguet

4 Faculty of Biology

S. Doetsch

4 Faculty of Biology

K. Aumann

8 Institute of Surgical Pathology, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

M Schiff

1 Department of Medicine I

L. M. Braun

1 Department of Medicine I

E. Haring

1 Department of Medicine I

B. A. Siranosian

9 Department of Genetics

A. S. Bhatt

9 Department of Genetics

P. Nordkild

11 Defensin Therapeutics, Copenhagen, Denmark

J. Wehkamp

12 Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany

B. A. H. Jensen

13 Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

J. Duyster

1 Department of Medicine I

R. Zeiser

1 Department of Medicine I

N. Köhler

1 Department of Medicine I